The Benefits of Trepidation

While wiping fear from our brains may seem attractive, the emotion is an essential part of our behavioral repertoire.

Nov 1, 2017
Abigail Marsh

BASIC BOOKS, October 2017Wouldn’t a life without fear be lovely?


It might seem that way. Intense fear not only feels exceedingly unpleasant, it can, in its extreme forms, disrupt life. The one in five American adults who are affected by anxiety disorders such as phobias and posttraumatic stress disorder might feel that ridding themselves of fear entirely would be a blessing.

But there is something much worse than too much fear—too little of it. For fear is an emotion with deep and vital benefits, not only for the people experiencing it, but for those around them.

Fear’s most obvious advantage is that it motivates escape in the face of danger—or the avoidance of danger in the first place. Without fear, basic urges for self-preservation evaporate.

Neuroscientists have learned this from studying people in whom injury or disease has damaged the amygdala, a critical hub of the brain’s fear network. These patients experience lives peppered with danger and trauma, much of it avoidable but not avoided. In one such patient, known only as SM, a congenital condition completely destroyed her amygdala and, with it, her capacity for fear. Although her intellect and reason are intact, she cannot detect or learn to avoid dangerous environments, and she has repeatedly found herself in life-threatening situations. SM has been held up at gunpoint and knifepoint, the latter by an obviously threatening stranger she approached, and has been the victim of multiple assaults. She has had to be stopped from touching poisonous snakes and spiders by the researchers who study her. Her son reports that when he was young, SM spotted a massive snake spanning the road near their house. Her response? To race toward the snake, pick it up, then set it loose in her yard.

Fear carries less obvious but no less significant social benefits as well, such as the ability to empathize with others’ fear. This is because interpreting others’ emotions involves the same machinery used to experience those emotions. The sight of another person’s fear—the wide eyes and raised and contorted brows of a fearful facial expression, for example—normally sparks activation in the amygdala and other brain structures that together may enable the viewer to internally simulate that state. As my lab’s research has demonstrated, the ability to empathize with others’ fear may motivate altruism, including extraordinary acts such as donating a kidney to a stranger. By contrast, not only are SM and others like her unable to experience fear normally, they also have difficulty understanding others’ fear. Without functioning amygdalas, they are reliably stumped when asked to interpret the meaning of even a clearly frightened-looking face. In this sense, they can be said to lack a fundamental form of empathy.

A similar problem seems to lie at the heart of a psychological disorder characterized by catastrophic empathy deficits: psychopathy. People with psychopathic traits are set apart even from other aggressive or antisocial people by their lack of remorse, compassion, and empathy. A critical clue to the cause of these traits has emerged from behavioral research: psychopaths—just like SM—have significant and specific impairments in recognizing fear in others, which brain imaging studies reveal are underpinned by amygdala dysfunction. Findings from my laboratory show that the weak amygdala response to others’ fear consistently observed in psychopathic adolescents and adults may serve as a biomarker of sorts for the kinds of goal-directed, cold-hearted aggression for which psychopaths are notorious. These findings suggest that amygdala dysfunction leaves such people struggling to recognize when others are afraid—and keeps them from really even understanding what being afraid feels like. This impairment leaves them unmoved by the prospect of threatening or hurting people, or engaging in other behaviors that cause fear.

It seems that Franklin Delano Roosevelt was wrong, then, when he said, “The only thing we have to fear is fear itself.” Deployed appropriately, fear can be a vital tool and guide in both the physical world and the social one.

What we need really to fear is those who lack this guide entirely. 

Abigail Marsh is an associate professor of psychology and neuroscience at Georgetown University. She directs its prize-winning Laboratory on Social and Affective Neuroscience. Read an excerpt of  The Fear Factor: How One Emotion Connects Altruists, Psychopaths, and Everyone In-Between at

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb


Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.